Biosimilar to Infliximab Is Effective for Inducing Remission in Crohn Disease

The first randomized, head-to-head study demonstrates noninferiority of CT-P13.

Source link

Related posts

Alzheimer’s drug may help treat opioid addiction


AGA Guidelines on the Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in adults (IBS-D): Patient Summary


Despite increases in CRC screening, racial disparities persist


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy